Compare Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. (JMAS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. trades at Rp228 (market cap 228B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| JMAS | OBAT | |
|---|---|---|
Market Cap | 228B | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk.
PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk (the Company) was established under the laws and regulations of the law Republic of Indonesia originally under the name "PT Jasa Mitra Abadi", domiciled in South Jakarta based on Notarial Deed No. 22 dated August 15, 2014, by Rosida Rajagukguk Siregar, Bachelor of Law, Master of Notary, Notary in South Jakarta.
Read more on JMAS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
